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Age-related loss of muscle mass and force (sarcope-
nia) contributes to disability and increased mortality.
Ryanodine receptor 1 (RyR1) is the skeletal muscle
sarcoplasmic reticulum calcium release channel
required for muscle contraction. RyR1 from aged
(24 months) rodents was oxidized, cysteine-nitro-
sylated, and depleted of the channel-stabilizing sub-
unit calstabin1, compared to RyR1 from younger
(3–6 months) adults. This RyR1 channel complex
remodeling resulted in ‘‘leaky’’ channels with in-
creased open probability, leading to intracellular
calcium leak in skeletal muscle. Similarly, 6-month-
oldmice harboring leaky RyR1-S2844Dmutant chan-
nels exhibited skeletal muscle defects comparable to
24-month-old wild-type mice. Treating aged mice
with S107 stabilized binding of calstabin1 to RyR1,
reduced intracellular calcium leak, decreased reac-
tive oxygen species (ROS), and enhanced tetanic
Ca2+ release, muscle-specific force, and exercise
capacity. Taken together, these data indicate that
leaky RyR1 contributes to age-related loss of muscle
function.
INTRODUCTION
A hallmark of aging is the progressive decline in skeletal muscle
function, characterized by reduced force generating capacity
and loss of muscle mass (Rolland et al., 2008; Vijg and Campisi,
2008). Moreover, age-dependent deterioration of muscle func-
tion is not restricted to mammals as it is also observed in many
animals including the nematode Caenorhabditis elegans (Hern-
don et al., 2002). Indeed, loss of muscular strength is highly
predictive of frailty, disability, and mortality with increased age
(Marzetti and Leeuwenburgh, 2006; Metter et al., 2002; Ranta-
nen et al., 1999). Progressive development of muscle dysfunc-
tion is common in aged humans and in animal models of aging
(Marzetti and Leeuwenburgh, 2006), and affects as many as
30%–50% of 80-year-olds leading to profound loss of function
in the elderly (Rolland et al., 2008).196 Cell Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier IncMuch attention has been focused on understanding how to
reverse age-relatedmuscle wasting, but there are no established
treatments for sarcopenia at this time (Marzetti and Leeuwen-
burgh, 2006; Saini et al., 2009; Thomas, 2007). In contrast,
improving specific force production, which is also significantly
reduced in aged muscle (Brooks and Faulkner, 1988; Gonza´lez
et al., 2000), has received less attention.
The observed loss of specific force in aged muscle suggests
that the Ca2+ dependent process known as excitation-contrac-
tion (EC) coupling may be impaired in aging. During muscle
contraction, membrane depolarization activates voltage-
sensing Ca2+ channels in the transverse tubules (Cav1.1) that
in turn activate the sarcoplasmic reticulum (SR) Ca2+ release
channel, ryanodine receptor 1 (RyR1). The subsequent rise in
cytoplasmic [Ca2+]cyt is critical for activation of actin-myosin
cross-bridging, shortening of the sarcomere and muscle
contraction (Allen et al., 2008; Andersson and Marks, 2010).
The RyR1 is a homotetrameric macromolecular protein complex
that includes four RyR1 monomers (565,000 Da each), the
RyR1 channel-stabilizing subunit calstabin1 (FK506 binding
protein 12, FKBP12), kinases, a phosphatase (PP1), phosphodi-
esterase (PDE4D3), and calmodulin (Zalk et al., 2007). Moreover,
maladaptive cAMP-dependent protein kinase A (PKA)-mediated
phosphorylation and redox-dependent modifications (cysteine-
nitrosylation and oxidation) of the RyR1 have been linked to
impaired Ca2+ handling and contractile dysfunction in chronic
muscle fatigue, heart failure and muscular dystrophy (Allen
et al., 2008; Bellinger et al., 2008, 2009; Zalk et al., 2007). Defec-
tive SR Ca2+ release has been reported in age-dependent
muscle weakness (Gonzalez et al., 2003; Jime´nez-Moreno
et al., 2008) and maladaptive modifications of the RyR1 macro-
molecular complex have been implicated in this condition (Russ
et al., 2011). However, the mechanism underlying impaired SR
Ca2+ release in aging muscle remains to be elucidated.
Oxidative stress occurs in aged muscle (Jang et al., 2010;
Moylan and Reid, 2007) and stress-induced protein oxidation
increases with age (Jackson, 2009; Muller et al., 2007). Two
important redox-dependent cellular mediators are cysteine-
nitrosylation (SNO) and carbonyl modifications of proteins.
Both nitrosylation and oxidation have been shown to affect skel-
etal muscle RyR1 function and Ca2+ signaling (Aracena-Parks
et al., 2006; Barreiro and Hussain, 2010; Hidalgo, 2005). Jang
et al. (2010) showed that ablation of the antioxidant enzyme
superoxide dismutase 1 (SOD1) increased superoxide levels in.
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accelerated age-dependent muscle pathology. Increased levels
of reactive oxygen species (ROS) in the aged muscle are associ-
ated with altered cellular Ca2+ handling. Mice with a malignant
hyperthermia mutation (Y522S) in RyR1 exhibit SR Ca2+ leak,
which promotes mitochondrial dysfunction and oxidative
stress-mediated changes of the RyR1 (Durham et al., 2008).
Moreover, oxidation-dependent modifications of RyR1 can
increase SR Ca2+ leak and a vicious cycle between RyR1-
mediated SR Ca2+ leak and mitochondrial ROS production has
been proposed (Durham et al., 2008). Furthermore, SNO-modifi-
cation of the RyR1 has been shown to disrupt the interaction
between RyR1 and calstabin1, resulting in channels that can
leak SR Ca2+, leading to reduced SR Ca2+ release and muscle
function (Bellinger et al., 2009; Zalk et al., 2007).
In the present study, we explored the role of RyR1 dysfunction
as an underlying mechanism for defective Ca2+ handling in age-
dependent and stress-induced muscle weakness. Fast twitch
muscles from aged mice (2 years old) exhibited reduced
specific force and cytoplasmic Ca2+ transients. Moreover,
RyR1 from aged rodents was oxidized, cysteine-nitrosylated,
and depleted of calstabin1, resulting in ‘‘leaky’’ RyR1manifested
as increased single-channel open probability and Ca2+ spark
frequency. Six-month-old mice genetically engineered to
express constitutively leaky RyR1 channels (RyR1-S2844D)
exhibited defective muscle function comparable that observed
in 24-month-old wild-type (WT) mice. Mice with a muscle-
specificdeletionof calstabin1had reducedmuscle-specific force
and impaired exercise capacity. Furthermore, WT flexor digito-
rum brevis (FDB) muscle fibers that were acutely treated with
rapamycin to dissociate calstabin1 from RyR1 (Ahern et al.,
1997; Brillantes et al., 1994) exhibited increased resting mito-
chondrial [Ca2+], loss of mitochondrial membrane potential, and
increased ROS and reactive nitrogen species (RNS) production.
Muscle from aged mice with mitochondrially targeted catalase
that exhibit reducedmitochondrialROS (Leeet al., 2010; Schriner
et al., 2005) showed markedly reduced RyR1 oxidation. Taken
together, these data suggest that RyR1-mediated SR Ca2+ leak
causes mitochondrial Ca2+ overload and increased ROS
production, which in turn further exacerbates the RyR1 SR
Ca2+ leak by oxidizing the channel. Thus, age-related loss of
muscle function and muscular dystrophy, in which RyR1 are
also leaky (Bellinger et al., 2009), likely share a common mecha-
nism that contributes to impaired exercise capacity. Treatment
with the RyR-stabilizing compound, S107, preserved the RyR1-
calstabin1 interaction and restored tetanic Ca2+ release,muscle-
specific force, and exercise capacity in aged mice, but not in
calstabin1-deficient mice, suggesting that S107 inhibits intracel-
lular Ca2+ leak by restoring the binding of calstabin1 to RyR1.
RESULTS
Oxidation-Dependent Remodeling of RyR1
and Defective SR Ca2+ Release in Aged Muscle
We examined extensor digitorum longus (EDL) muscles from
aged (24-month-old) C57BL/6 mice to explore the potential
role of RyR1 dysfunction in aging skeletal muscle. EDL from
aged mice exhibited reduced specific force compared to EDL
from young (3- to 6-month-old) controls (mean specific force atCel70 Hz tetanic contraction ± SEM: aged, 251 ± 21 kNm2, versus
young, 388 ± 14 kNm2; n = 5 aged, 7 young, p < 0.001) (Figures
1A–1C). Isolated fast twitch muscle FDB fibers from aged mice
also exhibited significantly reduced tetanic Ca2+ transients
compared to FDB fibers from young mice (mean DF/F0 at
70 Hz tetanic contraction ± SEM: aged, 4.4 ± 0.6, versus young,
6.8 ± 0.9; n = 8 aged, 10 young, p < 0.05) (Figures 1D–1F).
ROS were measured in FDB fibers using a cell-permeant form
of the fluorescent indicator 20,70-dichlorodihydrofluorescein di-
acetate, acetyl ester (DCF) (Aydin et al., 2009; Durham et al.,
2008). Muscle fibers from aged mice exhibited oxidative stress
with significantly increased levels of DCF fluorescence
compared to fibers from young adult mice (see Figures S1A
and S1B available online). To determine whether the observed
reductions in muscle-specific force and tetanic Ca2+ release
were associated with oxidation-dependent remodeling of the
RyR1 macromolecular complexes, RyR1 from aged and young
adult murinemuscles was immunoprecipitated and immunoblot-
ted for components of the RyR1 complex (Bellinger et al., 2009).
Skeletal muscle RyR1 complexes from aged mice exhibited
significantly increased nitrosylation and oxidation, and depletion
of calstabin1, compared to channels from young adult mice
(Figures 1G and 1H). Similar remodeling of the RyR1 complex
was observed in skeletal muscles from 24-month-old rats
(Figures S2A and S2B). Aging is known to be associated with
oxidative stress and mitochondrial abnormalities (Haigis and
Yankner, 2010). EDL muscle from 24-month-old WT mice exam-
ined by electron microscopy exhibited a significant increase in
mitochondria with disorganized or absent cristae compared to
EDLmuscle from young adult mice (Figures S3A, S3B, and S3E).
RyR1 Ca2+ Leak Causes Mitochondrial Dysfunction
in Skeletal Muscle
Transient increases of mitochondrial [Ca2+] enhance ATP
production (Brookes et al., 2004; Duchen, 2000), whereas pro-
longed and excessively elevated mitochondrial [Ca2+] impair
mitochondrial function due to dissipation of the mitochondrial
membrane potential (DJm) and increased ROS production
(Brookes et al., 2004; Duchen, 2000). To test whether RyR1-
mediated SR Ca2+ leak can lead to mitochondrial dysfunction
we measured changes in mitochondrial/cytosol [Ca2+] and
mitochondrial membrane potential in FDB muscle fibers in the
presence of rapamycin (15 mM), which causes SR Ca2+ leak by
disrupting RyR1-calstabin1 interactions (Ahern et al., 1997;
Brillantes et al., 1994). FDB fibers loaded with Rhod-2 were
used to measure mitochondrial Ca2+ (Aydin et al., 2009; Bruton
et al., 2003). Fibers were costained with Mitotracker Green to
confirm that Rhod-2 was loaded into mitochondria (Figures
S4A–S4C). Rapamycin treatment caused a time-dependent
increase in the Rhod-2 signal, indicating Ca2+ accumulation in
the mitochondria (Figure 2A). We next measured mitochondrial
membrane potential in FDB fibers using the fluorescent indicator
tetra-metyl rhodamine ethyl ester (TMRE) (Aydin et al., 2009;
Duchen, 2004; Nagy et al., 2011). Rapamycin induced a progres-
sive reduction in the TMRE signal (Figure 2B). At the end of each
experiment, an uncoupler of themitochondrial membrane poten-
tial (carbonyl cyanide p-trifluoromethoxyphenylhydrazone
[FCCP]) was added to the muscle fiber resulting in a further
reduction in TMRE fluorescence (Figure 2B). Rapamycin hasl Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Inc. 197
Figure 1. Impaired Force Production and Reduced
SR Ca2+ Release in EDL Muscle from Aged Mice
(A and B) Tetanic contractions of EDL muscle from young
(A) and aged (B) mice (force normalized to cross-sectional
area).
(C) Average force at the indicated stimulation frequencies
in EDL muscles from young and aged mice (mean ± SEM,
n = 5 [young], 7 [aged], p < 0.05 among groups at all
stimulation frequencies).
(D and E) Normalized Fluo-4 fluorescence in FDB muscle
fibers during a 70 Hz tetanic stimulation.
(F) Peak Ca2+ responses in FDB fibers stimulated at 70 Hz
(fibers taken from the same animals as in A and B; mean ±
SEM, n = 8 [young], 10 [aged], *p < 0.05).
(G) Immunoblots of immunoprecipitated RyR1 from young
and aged mice.
(H) Bar graphs show quantification of the immunoblots
in G (mean ± SEM, n = 2, **p < 0.01, ***p < 0.001). DNP,
2,4-dinitrophenylhydrazone; P*RyR1, phosphorylated
RyR1 (at serine 2844). See also Figures S1 and 2A.
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tions including inhibition of mTOR signaling. FK506 similarly
depletes calstabin1 from RyR1 channels, but does not inhibit
mTOR (Brillantes et al., 1994) and caused a reduction in the
TMRE signal similar to rapamycin (Figure S4D). Moreover, rapa-
mycin had no effect on mitochondrial membrane potential in
FDB muscle from mice with a skeletal muscle targeted defi-
ciency in FKBP12 (calstabin1) (Tang et al., 2004) (Figure S4E).
Together, these results indicate that inhibiting RyR1-calstabin1
binding leads to Ca2+ leak and mitochondrial dysfunction. Mito-
chondrial dysfunction is typically associated with increased ROS
production. We used the fluorescent indicator MitoSOX Red to
measure mitochondrial superoxide (O2*
) production (Aydin
et al., 2009). Rapamycin caused an increase in the MitoSOX
Red signal (control: 114% ± 6%, N = 5, rapamycin: 171% ±
8%, N = 10, p < 0.01) (Figure 2C). At the end of each experiment
the electron transport chain inhibitor Antimycin A (10 mM) was
applied as a positive control (Mukhopadhyay et al., 2007). Ca2+
leak and ROS production in muscle are associated with
increased reactive nitrogen species (RNS) (Durham et al.,
2008) and increased nitrosylation of the RyR1 was observed in
skeletal muscle from aged mice (Figure 1G). We loaded FDB
fibers with the fluorescent RNS indicator DAF-FM (DAF) to
examine the effects of leaky RyR1 on RNS production. In the
presence of rapamycin, DAF fluorescence increased signifi-
cantly compared to untreated controls (rapamycin: 121% ±
3%, baseline: 102% ± 5%, p < 0.001, N = 6) (Figure 2D), consis-
tent with increased RNS production. Taken together, our data
indicate that acute induction of RyR1-mediated SR Ca2+ leak198 Cell Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Inc.leads to defective mitochondrial function asso-
ciated with elevated ROS and RNS production.
The small molecule S107 inhibits SRCa2+ leak
by reducing the stress-induced depletion of
calstabin from the RyR channel complex (Ander-
sson and Marks, 2010; Bellinger et al., 2009;
Lehnart et al., 2008). Therefore, we sought to
determine whether the rapamycin-induced
Ca2+ leak and the consequent detrimentaleffects on mitochondrial membrane potential could be pre-
vented by treatment with S107. FDB fibers from young WT
mice were incubated with S107 (5 mM) for 2–3 hr before the start
of the experiment (Shan et al., 2010). The rapamycin-induced
increase in Rhod-2 fluorescence as well as the loss of mitochon-
drial membrane potential and increase in MitoSOX Red and DAF
signals were prevented by S107 (Figures 2A–2D) whereas inter-
mittent twitch stimulation of the FDB fibers (that causes large but
transient increases in cytoplasmic [Ca2+]) did not alter the mito-
chondrial membrane potential (Figure 2B). These data indicate
that pathologic SR Ca2+ leak, but not action potential-mediated
SRCa2+ release, have detrimental effects onmitochondrial func-
tion and that the effects of pathologic Ca2+ leak onmitochondrial
membrane potential could be prevented by S107 treatment.
Inhibiting RyR1 Ca2+ Leak Improves Muscle Force
and Exercise Capacity
Aged mice were housed individually in cages equipped with
running wheels, and voluntary running time and distance were
continuously recorded. Fifty percent of the aged mice (n = 13)
were supplied with S107 (50 mg kg1 d1) in their drinking
water for a 4 week period, whereas the other half (n = 14)
served as the control group. Water consumption was not
different between the S107 and vehicle groups (average
daily consumption in ml, aged + S107, 8.4 ± 0.63; aged, 7.9 ±
0.4; ± SEM, p = NS). The S107-treated mice exhibited signifi-
cantly increased running distance (aged + S107, 94 ± 14 km;
aged, 57 ± 7 km; mean total distance in 4 weeks, ± SEM,
p < 0.05) (Figure 3A) and average speed (S107, 155 ± 20 m/hr;
Figure 2. Effects of SR Ca2+ Leak on Mitochondrial
Membrane Potential, ROS, and RNS Production in
Skeletal Muscle Fibers
(A) Rapamycin-induced increase in mitochondrial Ca2+
measured with the fluorescent indicator Rhod-2. The
Rhod-2 signal was measured from three mitochondria rich
regions in each cell (mitochondria-rich regions were
confirmed using mitotracker green; see Figure S4) and
normalized to baseline; *p < 0.05 indicates significant
difference of the control rapamycin (N = 7) compared to
S107 (N = 6) and control no rapamycin (N = 4) groups
(ANOVA). In the S107 rapamycin group FDB fibers were
incubated with S107 (5 mM) for 2–4 hr before starting the
experiment.
(B) Changes in mitochondrial membrane potential (mea-
sured with TMRE fluorescence) with respect to different
interventions. Arrow indicates onset of rapamycin (for
groups control rapamycin and S107 rapamycin) or repeti-
tive twitch stimulation without rapamycin (twitching).
The dashed line indicates application of FCCP (300 nM).
*p < 0.05 indicates significant difference (ANOVA) among
the groups control rapamycin (n = 5) and control no
rapamycin (n = 3) or group twitching (n = 6) or S107
rapamycin (n = 5).
(C) Mitochondrial superoxide production in FDB fibers
measured with MitoSOX Red. Arrow indicates when
rapamycin was applied. The dashed line indicates appli-
cation of Antimycin A (10 mM) as a positive control for
superoxide production. Control rapamycin (n = 8), Control no rapamycin (n = 5), S107 rapamycin (n = 5). *p < 0.05 indicates significant difference between the
control rapamycin group and no rapamycin or S107 groups (ANOVA).
(D) The effect of rapamycin-induced Ca2+ leak on RNS production in FDB fibers measured with the RNS indicator DAF. Arrow indicates application of rapamycin.
The NO donor S-nitroso-N-acetylpenicillamine (SNAP; 100 nM) was applied as a positive control at the end of each experiment (indicated by dashed line). Control
rapamycin (n = 6), control no rapamycin (n = 6), S107 rapamycin (n = 5). *p < 0.05 indicates significant difference (ANOVA) for the control rapamycin group
compared to the S107 and no rapamycin groups. All data are shown as mean ± SEM. See also Figure S4.
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period, ± SEM, p < 0.01). Moreover, the S107-treated mice ex-
hibited more episodes at higher running speeds (Figure 3B).
Thus, S107-treated aged mice exhibited increased exercise
capacity and exercised at higher intensity levels compared to
controls.
To determine the mechanism underlying the improved exer-
cise capacity in S107-treated aged mice, we measured muscle
force production. There was a significant increase in specific
force at all stimulation frequencies in the EDL muscles from the
S107-treated mice (mean force at 70 Hz tetanic contraction ±
SEM: aged, 201 ± 21 kNm2, aged + S107, 320 ± 19 kNm2;
p < 0.001) (Figures 3C–3E). The average tetanic forces for EDL
muscles from untreated aged mice at 70 Hz in the experiments
shown in Figures 1 and 3 were not significantly different (aged
mice, Figure 1: 250 ± 21 kN/m2, n = 5; aged mice, Figure 3:
196 ± 19 kN/m2, n = 6; p = NS; t test). The cross-sectional area
of EDL muscle fibers from aged mice were slightly smaller
compared to young mice (Figure S5). There was no difference
in the fiber size between S107-treated versus untreated aged
mice (Figure S5). Furthermore, EDL muscle mass was not
different between the S107 and vehicle-treated aged mice
(aged + S107, 12.7 ± 0.6 mg; aged, 13.8 ± 0.6 mg; p = 0.22).
EDL muscles used in the force measurements were also
analyzed for posttranslational modifications of RyR1. There
were no differences in the levels of nitrosylation, oxidation or
PKA phosphorylation of RyR1 from muscles from mice treated
with S107 versus control. This suggests that the oxidativeCelprotein modifications are irreversible, as has been reported
(Palmese et al., 2011), and protein nitrosylation may have
a half-life longer than the 4 weeks of S107 treatment, which
has also been reported (Hess et al., 2005). Muscles from the
S107-treated mice did, however, show significantly more calsta-
bin1 in the RyR1 complexes compared to skeletal muscle from
control mice (Figures 3F and 3G).
To determine whether the improvement in exercise and
muscle-specific force were associated with improved SR Ca2+
release, Ca2+ responses to tetanic stimulation were recorded
in FDB myocytes from S107-treated and control mice. Tetanic
Ca2+ transients were significantly increased in FDB myocytes
from S107-treated mice compared to those from the control
group (mean DF/F0 at 70 Hz tetanic contraction ± SEM: aged,
3.7 ± 0.3; S107, 5.9 ± 0.5; n = 13, p < 0.01) (Figures 4A–4C).
Thus, the improved tetanic SR Ca2+ release in muscles from
S107-treated aged mice accounts for the observed increase in
muscle force production (Figures 3C–3E). In order to assess
the effects of S107 treatment on the single-channel properties
of isolated skeletal muscle RyR1 channels, SR membranes
were prepared from EDL muscles and fused to planar lipid
membrane bilayers, and Ca2+ fluxes through RyR1 channels
were recorded as previously described (Brillantes et al., 1994)
using conditions that simulate resting muscle (150 nM Ca2+ on
the cis, ‘‘cytosolic’’ side of the channel). The open probability
(Po) of skeletal muscle RyR1 channels from young mice was
low, as expected for normal skeletal muscle RyR1 channels
(Figures 4D and 4E). In contrast, skeletal muscle RyR1 channelsl Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Inc. 199
Figure 3. Improved Exercise Capacity, Muscle-
Specific Force, and Increased Calstabin1 in the
RyR1 Complex Following S107 Treatment of Aged
Mice
(A) Daily voluntary running distance in aged mice ± S107
treatment (mean ± SEM, n = 13 aged + S107, n = 14 aged,
*p < 0.05, ANOVA). The arrow indicates start of the S107
treatment.
(B) Histogram showing the distribution of the number of
5 min episodes in which the mice ran at a given speed. The
insert shows the tail of the histogram at expanded time
scale. Note the increased number of high-speed episodes
in S107-treated mice compared to control.
(C and D) Tetanic contractions (70 Hz) in isolated EDL
muscles from aged and S107-treated aged mice.
(E) Average specific force in EDL muscles from the same
mice as in A (mean ± SEM, n = 6 young, 7 aged, *p < 0.05,
***p < 0.001).
(F) Immunoblot of immunoprecipitated RyR1 from aged
murine skeletal muscle. Aged EDL muscles taken from the
mice in (A) and (E).
(G) Quantification of the immunoblot in (F). S107 reduced
depletion of calstabin1 from the RyR1 complex in skeletal
muscle from aged mice (mean ± SEM, n = 3, **p < 0.01,
compared to young). See also Figures S1 and S2.
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whereas channels from S107-treated aged mice displayed
normal, low Po (Figures 4D and 4E). Taken together, these data
suggest that S107 treatment improves exercise capacity in
aged mice by reducing the loss of calstabin1 from the channel
complexes, and restoring normal (nonleaky) channel function,
which in turn results in improved tetanic Ca2+ and muscle-
specific force production.
To further test the hypothesis that the RyR1 channels in aged
muscle are leaky we recorded spontaneous releases of SR Ca2+,
i.e., Ca2+ sparks (Bellinger et al., 2009; Shirokova and Niggli,
2008; Ward et al., 2003), in permeabilized EDL muscle fiber
bundles from S107-treated and muscles from untreated adult
and aged mice. Ca2+ spark frequency was significantly
increased in muscle fibers from aged compared to young mice
examined under identical conditions by blinded observers
(Figures 5A and 5B). Furthermore, S107 treatment in vivo re-
sulted in significantly reduced Ca2+ spark frequencies in EDL
muscle from aged mice (Figures 5A and 5B). Thus, both the
increased Ca2+ spark frequency and RyR1 Po in muscle from
the aged mice support a model in which leaky RyR1 channels
are associated with defective SR Ca2+ release and reduced
muscle force production. These defects can be reversed using
S107 that inhibits the RyR1-mediated SR Ca2+ leak by prevent-
ing depletion of the calstabin1 subunit from the channel
complex, resulting in stabilization of the closed state of the
channel in resting muscle (Brillantes et al., 1994).200 Cell Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Inc.S107 Requires Calstabin1 to Reduce Ca2+
Leak and Improve Muscle Function
Extreme exercise and heart failure are both
associated with leaky RyR1 due to phosphory-
lation of RyR1 at serine 2844 resulting in skel-
etal muscle weakness (Shan et al., 2010; Bellin-
ger et al., 2008; Reiken et al., 2003). To furthertest whether leaky RyR1 can cause muscle weakness we devel-
oped a knock-in mouse model with a leaky RyR1 due to substi-
tution of aspartic acid for serine 2844 (RyR1-S2844D mouse).
Compared to WT muscles, EDL muscles from 6-month-old
RyR1-S2844D mice displayed increased Ca2+ spark frequency
(Figure 5B) and increased single RyR1 channel open probability
under resting conditions (Figures S6A–S6C). These abnormali-
ties observed in muscle from 6-month-old RyR1-S2844D mice
were comparable to those observed in 24-month-old WT
muscle, consistent with leaky RyR1. RyR1 from RyR1-S2844D
mice was progressively oxidized, nitrosylated, and depleted of
calstabin1 by 6 months of age (Figures 6A and 6B), again
comparable to changes observed in RyR1 complexes from
24-month-old WT mice. EDL muscles from the RyR1-S2844D
mouse exhibited a significant increase in mitochondria with
abnormal morphology (Figures S3C and S3E). Muscle-specific
force and action potential-triggered Ca2+ transient amplitudes
were reduced in the 6-month-old RyR1-S2844D mice
compared to WT mice (Figures 6C and 6D). Four weeks of
S107 treatment in vivo reduced the elevated Ca2+ spark
frequency (Figure 5B) and improved muscle force in 6-month-
old RyR1-S2844D mice, both to levels comparable to those
observed in muscle from young WT mice (Figure 6C). In
summary, the SR Ca2+ leak and impaired muscle force produc-
tion observed in skeletal muscle from 6-month-old RyR1-
S2844D mice were comparable to those found in 24-month-
old WT muscle.
Figure 4. S107 Reduces SR Ca2+ Leak, Resulting in
Enhanced Tetanic SR Ca2+ Release in Skeletal
Muscle from Aged Mice
(A and B) Ca2+ transients Fluo-4 fluorescence in FDB
muscle fibers during a 70 Hz tetanic stimulation in control
mice (A) and mice treated with S107 (B).
(C) Peak tetanic Ca2+ amplitudes in the two treatment
groups (muscle fibers were taken from the same animals
as in Figures 3A and 3B; mean ± SEM, n = 10–13,
**p < 0.01).
(D) Single-channel current traces of skeletal RyR1 chan-
nels isolated from young, aged, and aged + S107-treated
mice. Single-channel currents were measured at 150 nM
cytosolic [Ca2+] using Ca2+ as a charge carrier at 0 mV.
Channel openings are shown as upward deflections; the
closed (c-) state of the channel is indicated by horizontal
bars in the beginning of each trace. Tracings from over
3 min of recording for each condition showing channel
activity at two time scales (5 s in upper trace and 500 ms in
lower trace) as indicated by dimension bars, and the
respective Po, To (average open time), and Tc (average
closed time) are shown above each 5 s trace. The activity
of the channel indicated by the thick black bar is shown on
the expanded time scale (the 500 ms trace below).
(E) Bar graph summarizing Po at 150 nM cytosolic [Ca
2+] in
young n = 4, aged n = 5, and aged + S107-treated
n = 5 channels (mean ± SEM, *p < 0.05 [ANOVA]).
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mice can be attributed to the restored RyR1-calstabin1 binding
with the consequent reduction in SR Ca2+ leak, we conducted
a series of experiments in which we treated muscle-specific
calstabin1-deficient (calstabin1 KO) mice with S107. In agree-
ment with the results from Tang et al. (2004), we found that
muscle-specific calstabin1 KO mice exhibited reduced EDL
muscle-specific force (Figure 6E) compared to WTmice. Calsta-
bin1 KOmuscles had a ‘‘leaky RyR1’’ phenotype as indicated by
enhanced frequency of Ca2+ sparks compared to young WT
muscle (Figure 5B). Electron microscopy of EDL muscle from
the muscle-specific calstabin1 KO mouse revealed a significant
increase in mitochondria with abnormal morphology (Figures
S3D and S3E). Muscle-specific calstabin1 KO FDBmuscle fibers
loaded with the ROS indicator DCF had increased fluorescence
compared to the young WT, consistent with oxidative stress
(Figure S1). However, S107 treatment, which reduced DCF fluo-
rescence in aged WT mice, did not alter the DCF signal in
muscle-specific calstabin1 KO muscle, suggesting that the
ability of S107 to reduce SR Ca2+ leak and oxidative stress
requires calstabin1 (Figure S1). Consistent with a reduction in
muscle-specific force, action potential triggered Ca2+ release
measured in Fluo-4 loaded FDB fibers from muscle-specific cal-
stabin1 KO mice exhibited reduced Ca2+ transient amplitudes
compared to youngWT (Figure 6D). Moreover, exercise capacity
was reduced in the calstabin1 KO mice compared to WT (Fig-
ure 6E). Treatment with S107 in the drinking water (50 mg
kg1 d1) for 4 weeks did not restore specific force, Ca2+
transient amplitudes, Ca2+ spark frequency or the DCF signal
in calstabin1 KO muscle (Figures 5B, 6D, 6F, S1A, and S1B).
Furthermore, exercise capacity in young WT or calstabin1 KO
mice was not improved by S107 treatment (Figure 6F). Taken
together, these data indicate that the beneficial effects of S107Celon Ca2+ handling and muscle function observed in both aged
mice and in RyR1-S2844D mice require calstabin1 in skeletal
muscle. Moreover, RyR1 from calstabin1 KO mice was oxidized
and nitrosylated (Figures S2C and S2D). This suggests that ROS,
produced downstream of the SR Ca2+ leak, feeds back to the
RyR1 where it causes oxidative modifications.
To directly test the hypothesis thatmitochondrial-derived ROS
causes age-dependent RyR1 oxidation, we examined RyR1
oxidation in muscles from young (3 months) and aged
(18 months) transgenic mice with mitochondrial targeted over-
expression of catalase (MCAT) (Lee et al., 2010; Schriner et al.,
2005). RyR1 oxidation was substantially reduced, nitrosylation
slightly reduced and calstabin1 binding was preserved in
samples from aged MCAT mice compared to age-matched WT
controls (Figures 6G and 6H). We treated SR microsomes from
WT muscle with oxidizing (H2O2) and nitrosylating (Noc-12)
compounds alone and in combination to examine the effects of
these modifications in more detail. Either nitrosylation or oxida-
tion of the RyR1 led to partial depletion of calstabin1, whereas
a combination of these two posttranslational modifications led
to more extensive depletion (Figures S2E and S2F). Thus, oxida-
tion and nitrosylation of RyR1 appear to work additively with
respect to calstabin1 depletion.
DISCUSSION
In the present study, we show that oxidized RyR1 in muscle from
aged mice is depleted of calstabin1, resulting in leaky channels,
reduced tetanic Ca2+, decreased muscle-specific force, and im-
paired exercise capacity. To confirm that leaky RyR1 can cause
the defects in function observed in aged muscle, we generated
a leaky RyR1 model (RyR1-S2844D mice) and used muscle-
specific calstabin1-deficient mice. Both strains prematurelyl Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Inc. 201
Figure 5. Elevated Ca2+ Spark Frequency Is
Reversed by S107 in EDL Muscle from Aged WT
Mice and RyR1-S2844D Mice but Not in Calstabin1
KO Mice
(A) Line scans of Fluo-4 fluorescence from permeabilized
EDL muscle fibers (young: upper panel; aged: middle
panel; aged +S107: lower panel) showing Ca2+ spark
activity. The heat diagram indicates the normalized change
in fluorescence intensity (DF/F0).
(B) Bar graph showing average Ca2+ spark frequency (the
number of sparks examined were: 1219 in the young
mice, n = 530 line scans from 32 fibers and six animals;
7389 in the vehicle-treated aged mice, n = 505 line
scans from 30 fibers and six animals; 3713 in aged mice
treated with S107, n = 414 line scans from 25 fibers
and five animals; 673 in the untreated RyR1-S2844D
mice, n = 240 line scans from 15 fibers and three animals;
2405 in S107-treated RyR1-S2844D mice, n = 210 line
scans from 14 cells and three animals; mean ± SEM,
***p < 0.001 (ANOVA).
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24-month-old WT mice. Moreover, the small molecule rycal
drug S107, which preserves RyR1-calstabin1 binding and stabi-
lizes RyR1 channels, reduced Ca2+ spark frequency, improved
tetanic Ca2+ release, restored muscle-specific force, and
improved exercise capacity in aged WT mice. S107 had no
beneficial effects in muscle-specific calstabin1 KO mice,
indicating that the mechanism of action of the drug involves
calstabin1.
Our present study is consistent with previous reports showing
impaired Ca2+ release in aged muscle (Jime´nez-Moreno et al.,
2008), reduced SR Ca2+ release in SR vesicles (Russ et al.,
2011), and reduced caffeine-induced release of the SR Ca2+
store (Romero-Suarez et al., 2010). In addition to the pathologic
SR Ca2+ leak via remodeled RyR1 that we report in the present
study, other defects such as uncoupling between the voltage
sensor and RyR1 (Jime´nez-Moreno et al., 2008) may also
contribute to muscle weakness in aging.
Mitochondria are the primary source of superoxide (O2*
), and
in the presence of NO, O2*
 facilitates the production of reactive
nitrogen species (RNS) and protein nitrosylation (Szabo´ et al.,
2007). Skeletal muscle RyR1 is sensitive to redox changes
(Xia et al., 2000), and we have shown previously that leaky
RyR1 in muscular dystrophy and in muscle fatigue after extreme
exercise is cysteine-nitrosylated and depleted of calstabin1. In
this study we show that the skeletal muscle RyR1 from aged
mice are oxidized and nitrosylated. Moreover, the leaky RyR1
from RyR1-S2844D mice becomes progressively oxidized with
age. Furthermore, acute induction of SR Ca2+ leak with rapamy-
cin or FK506 or using muscle-specific calstabin1-deficient mice
increased ROS and RNS production. Taken together, these find-
ings suggest that SR Ca2+ leak may exacerbate mitochondrial
dysfunction by causing mitochondrial Ca2+ overload, which in
turn leads to increased RNS and ROS production. The increase
in oxidative stress would further promote RyR1 leak by further
oxidizing the channel and depleting it of the stabilizing subunit
calstabin1.
The 4 week S107 treatment partially reduced oxidative stress
in the aged muscle (Figure S1) but did not reduce oxidation
or cysteine-nitrosylation of the RyR1. Oxidation-dependent202 Cell Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Inccarbonyl modifications of proteins have been reported to be irre-
versible (Palmese et al., 2011). Thus, inhibiting SR Ca2+ leak
would decrease additional oxidation of the RyR1, but would
not necessarily reverse the oxidation of RyR1. SNO protein
modification is critically dependent on local production of NO,
e.g., by NO synthases (NOS). The stability of SNO protein
modifications are highly variable and can be influenced by
multiple factors including the protein topology, redox state and
pH in the vicinity of the affected protein (Hess et al., 2005). More-
over, although the effects of Ca2+ overload on mitochondrial
dysfunction and increased ROS production are multifactorial,
some of them are believed to be irreversible (Feissner et al.,
2009; Jekabsone et al., 2003). The half-life of the mitochondria
is 2–4 weeks (Kowald, 2001; Menzies and Gold, 1971) and the
half-life of the RyR1 protein is 10 days in muscle from aged
rats (Ferrington et al., 1998). Thus, the continued ROS produc-
tion frommitochondria and the slow turnover of the RyR1 protein
contribute to the observation that RyR1 oxidation is not reduced
during a 4 week course of S107 treatment, despite inhibition of
the intracellular Ca2+ leak. Moreover, ROS generation from non-
mitochondrial sources, e.g., nonphagocytic NAD(P)H oxidase
(NOX), could contribute as they have been reported to activate
RyR channels(Hidalgo et al., 2006; Xia et al., 2003). Our results,
however, are consistent with a ‘‘vicious cycle’’ whereby SR
Ca2+ leak and mitochondrial ROS are locally amplified and lead
to progressive age-dependent muscle dysfunction (Figure 7).
Moreover, our data show that despite persistent RyR1 oxidation
and nitrosylation, S107 treatment inhibits the loss of calstabin1
from RyR1 resulting in stabilization of the channel closed state.
Thus, S107 inhibits the pathologic SR Ca2+ leak, as long as
calstabin1 is present and ameliorates age-dependent loss of
muscle function, despite persistent oxidation and nitrosylation
of RyR1.
Our data showing increased Ca2+ spark frequency in skeletal
muscle from aged WT, RyR1-S2844D, and muscle-specific
calstabin1-deficient mice are at odds with a previous study
that reported reduced Ca2+ spark activity in aged skeletal
muscle (Weisleder et al., 2006). The discrepancy between our
results and those ofWeisleder et al. (2006) could be due to differ-
ences in methodology because Weisleder et al. (2006) used.
Figure 6. Improved Muscle Function and Exercise Capacity in S107-Treated Mice Requires Calstabin1
(A) Immunoblot of immunoprecipitated RyR1 fromWT, 1-month-old (1m), 6-month-old (6 m) RyR1-S2844Dmice, and 6-month-old (6m) RyR1-S2844Dmice that
were treated with S107 (from the same animals as in C).
(B) Quantification of band intensities in (A) (mean ± SEM, n = 3, **p < 0.01 compared to WT, ##p < 0.01 compared to S2844D 1 m, ANOVA). RyR1 from
RyR1-S2844D mice is progressively oxidized (DNP) and depleted of calstabin1 with age.
(C) EDLmuscle force-frequency curves in 6-month-old RyR1-S2844Dmice and youngWTmice. S107 treatment (4 weeks) significantly increasedmuscle force in
the RyR1-S2844D mice (mean ± SEM).
(D) Peak Ca2+ transient amplitudes at 70 Hz tetanic stimulation (peak Fluo-4 fluorescence [F] was normalized to resting fluorescence [F0], DF/F0).
(E) EDL muscle from muscle-specific calstabin1 KO mice produce significantly less force compared to young WT. S107 treatment (4 weeks) did not restore EDL
muscle force in muscle-specific calstabin1 KO mice.
(F) Daily voluntary running distance in young WT mice ± S107 treatment and in muscle-specific calstabin1 KO mice ± S107 treatment (mean ± SEM; *p < 0.05
[ANOVA]). The arrow indicates start of the S107 treatment.
(G) Immunoblot of immunoprecipitated muscle RyR1 from young WT, aged (18 months) WT, young transgenic mice with mitochondrial targeted overexpression
of catalase (MCAT), and aged (18 months) MCAT mice.
(H) Quantification of band intensities in (G) (mean ± SEM, n = 4 all groups; ***p < 0.001, ## p < 0.01 compared to agedWT [ANOVA]). The pooled data in the figure
are mean ± SEM; *p < 0.05, ***p < 0.001 (ANOVA); the number of samples are indicated in parentheses in the figure legend. See also Figure S2.
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Figure 7. Model of RyR1-Mediated SR Ca2+ Leak and Mitochondrial Dysfunction in Aging Skeletal Muscle
(A) Sarcoplasmic reticulum (SR) Ca2+ leak due to oxidation-dependent modifications of RyR1 exacerbates mitochondrial dysfunction and production of reactive
oxygen species (ROS). This causes remodeling of RyR1 resulting in SR Ca2+ leak, which impairs muscle force production.
(B and C) The RyR1 from young mice is not ‘‘leaky,’’ the SR Ca2+ stores are filled, and activation of the myocyte leads to SR Ca2+ release, which triggers muscle
contraction.
(D and E) In aging, ROS and reactive nitrogen species (RNS)-mediated remodeling of RyR1 results in dissociation of the RyR1-stabilizing subunit calstabin1 and
SR Ca2+ leak. Under these conditions, muscle activation will lead to reduced SR Ca2+ release and impaired muscle force. [Ca2+]m, mitochondrial [Ca
2+]; DJm,
mitochondrial membrane potential; RyR1, ryanodine receptor type 1; ROS, reactive oxygen species; SR, sarcoplasmic reticulum.
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the muscle cells to swell resulting in Ca2+ sparks. In contrast, we
used saponin permeabilized muscle fibers in order to control the
intracellular conditions (e.g., pH, [Ca2+], [Mg2+], and the Ca2+ dye
concentration), which is not possible using intact muscle fibers
(Isaeva et al., 2005; Rı´os et al., 1999; Shirokova and Niggli,
2008). We have previously used this method to study patholog-
ical conditions where RyR1 exhibited a leaky phenotype
(Bellinger et al., 2009; Reiken et al., 2003; Ward et al., 2003). In
addition, the increased Ca2+ spark frequency is consistent with
the increased RyR1 Po observed in the aged muscle.
Much of the focus in the field of aging is on therapeutics that
target anabolic pathways with hormones, including testos-
terone, growth hormone, and insulin-like growth factor-1 (Lynch,
2008; Rolland et al., 2008), to improve muscle mass. Some
studies have demonstrated increased muscle mass without
increased muscle strength or power (Lynch, 2008; Rolland
et al., 2008). Inhibition of the endogenous negative regulator of
myogenesis, myostatin (growth differentiation factor 8), leads
to a dramatic increase of muscle mass in mice and cattle (Lynch,
2008). However, muscular dystrophy patients that were treated
with an antimyostatin recombinant human antibody failed to204 Cell Metabolism 14, 196–207, August 3, 2011 ª2011 Elsevier Incimprove muscle power (Wagner et al., 2008). Thus, increasing
skeletal muscle mass is not necessarily accompanied by
improved muscle function. Indeed, treating aged mice with
S107 enhances muscle strength without increasing the size of
the muscle, at least during the 4 week period of treatment exam-
ined in the present study.
Despite the important role of oxidative stress in aging-depen-
dent pathologies, the use of dietary antioxidants as an experi-
mental treatment for sarcopenia has not demonstrated improve-
ment in muscle function (Kim et al., 2010). A complicating factor
is that systemic antioxidants could impair beneficial effects of
ROS (Jackson, 2009; Vijg and Campisi, 2008). By inhibiting the
SR Ca2+ leak via RyR1 that is due to oxidation, S107 appears
to be able to improve muscle function without blocking systemic
ROS-dependent signaling and may represent a promising thera-
peutic option for reducing age-dependent loss of muscle
function.
The regulatory mechanisms of aging are likely multifactorial
and several signaling pathways seem to contribute, e.g.,
changes in insulin/insulin like growth factor (IGF), sirtuins, AMP
kinase, and inflammatory signaling (Kenyon, 2010; Marzetti
and Leeuwenburgh, 2006). Moreover, mitochondrial dysfunction.
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2005; Larsson, 2010). In the present study, we show that leaky
RyR1, mitochondrial dysfunction, and oxidative stress conspire
to produce age-dependent muscle weakness and reduced exer-
cise capacity.
EXPERIMENTAL PROCEDURES
A detailed description is found in the Supplemental Information.
Animal Models
Agedmice (23–26months; C57BL/6) came from the National Institute of Aging,
and young mice (3–6 months, C57BL/6) came from our own breeding. Gener-
ation of RyR1-S2844D mice (Figure S7) is described in the Supplemental
Information. Muscle-specific cal1/ (calstabin1) mice were bred in the lab
after a breeding pair was generously provided to us by Susan Hamilton (Baylor
College of Medicine) (Tang et al., 2004). Muscle lysates from young and aged
mice with mitochondrial targeted overexpression of catalase (MCAT) were
generously provided to us by Gerald Shulman (Yale University), who used
mice provided by Peter S. Rabinovitch (University of Washington). The mice
in the drug treatment experiments were randomized into two groups. The first
group received S107 (50mg/kg/day) in the drinkingwater, whereas the second
group received water only. Voluntary exercise (running wheel) intensity was
recorded continuously. All experiments were performed by blinded observers
and were conducted in accordance with Columbia University Institutional
Animal Care and Use Committee regulations.
Force and Ca2+ Measurements
EDL and FDB muscles were dissected. Force measurement was done on
whole EDL muscle using a system from Aurora Scientific (Ontario, Canada).
For Ca2+ spark measurements, saponin-permeabilized fiber bundles from
EDLwere loadedwith the fluorescent Ca2+ indicator Fluo-3, and the frequency
of spontaneous SR Ca2+ release was imaged using a confocal microscope
(Zeiss, LSM 5 live) in line-scan mode. Intact muscle fibers from enzymatically
dissociated FDB muscles (Aydin et al., 2009) were loaded with the Ca2+ indi-
cator Fluo-4 AM. The FDB fibers were electrically stimulated to tetanic
contraction, and the Fluo-4 signal was imaged using a confocal microscope
(Zeiss, LSM 5 live).
Measurements of Mitochondrial Ca2+, Mitochondrial Membrane
Potential, ROS, and RNS
Enzymatically isolated FDB muscle fibers were loaded with the fluorescent
indicators Rhod-2 and the mitochondrial markers Mitotracker green, TMRE,
MitoSOX Red, DCF, and DAF-FM to measure mitochondrial Ca2+, mitochon-
drial membrane potential, ROS, and RNS, respectively.
RyR1 Immunoblotting
Muscle samples were prepared as described (Bellinger et al., 2009). Immuno-
blots were developed with anti-RyR (Affinity Bioreagents, Boulder, CO;
1:2000), anti-phospho-RyR1-pSer2844 (1:5000), an anti-Cys-NO antibody
(Sigma, St. Louis; 1:2000), or an anti-calstabin antibody (1:2500). To determine
channel oxidation, the carbonyl groups in the protein side chains within the
immunoprecipitate are derivatized to 2,4-dinitrophenylhydrazone (DNP-
hydrazone) by reaction with 2,4-dinitrophenylhydrazine (DNPH). The DNP
signal associated with RyR is determined using an anti-DNP antibody.
Single RyR1 Channel
Crude SR vesicles containing RyR1 were fused to planar lipid bilayers.
Conductance through the RyR1 was measured using Ca2+ as the charge
carrier. RyR1 openings were quantified and open probability (Po) was
calculated.
Histology and Electron Microscopy
Preparation of tissue samples and microscopy was performed according to
established methods as described in the Supplemental Experimental
Procedures.CelSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, and seven figures and can be found with this article
online at doi:10.1016/j.cmet.2011.05.014.
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